Paige Ashley Hargis
Research Subjects
Research Interests
Paige Ashley Hargis has a total of 8 co-authors. Here are the top co-authors by number of shared publications:
- Geoffrey H. Rosen
Division of Urology, Department of Surgery, University of Missouri at Columbia, Columbia, MO
3 shared publications - Katie S. Murray
Department of Urology
3 shared publications Alp Kahveci
School of Medicine
2 shared publications- Andrew Moss
Department of Anesthesia
2 shared publications - Connor Lough
Department of Urology
2 shared publications - Mojgan Golzy
University of Missouri, USA
2 shared publications
Latest Publications
- 1 September 2023
- Published by Wolters Kluwer Health in Journal of Urology
- Vol. 210 (3) , 528
Reply by Authors
- 1 September 2023
- Published by Wolters Kluwer Health in Journal of Urology
- Vol. 210 (3) , 528
Reply by Authors
- 1 September 2023
- Published by Wolters Kluwer Health in Journal of Urology
- Vol. 210 (3) , 517-528
Randomized Controlled Trial of Single-dose Perioperative Pregabalin in Ureteroscopy
Ureteroscopy is a commonly performed procedure, with post operative pain that can lead to re-visits and opioid prescribing. Perioperative gabapentinoids have shown promise in decreasing pain and opioid use. We hypothesized that single dose perioperative pregabalin would be safe and efficacious for decreasing pain after ureteroscopy. This was an IRB approved and registered blinded, placebo-controlled trial conducted at a single institution. Patients undergoing ureteroscopy without histories that would limit use of opioids, gabapentinoids, and non-steroidal medications were enrolled. Either 300mg pregabalin or placebo was administered 1 hour before ureteroscopy. Pain was assessed using a visual analogue before administration and 1 hour after surgery. Clinical factors, pain scores, a proxy for cognition, patient satisfaction, and opioid prescribing were assessed in the first 30 post operative days. 118 patients were enrolled over a 2-year period. Patients who received pregabalin were younger than those who received placebo (median of 44 years vs 57). Post operative pain scores were higher in those who received pregabalin (3.7 vs 2.0, P = .004), a finding that remained statistically significant when accounting for patient age and preoperative pain scores. There was no difference in the measure of cognition or in reports of adverse events. In this trial evaluating the efficacy of a single dose perioperative pregabalin in ureteroscopy, pregabalin did not decrease postoperative pain when compared to placebo. Urologists should not routinely use this adjunctive medication in ureteroscopy, as it is unlikely to provide benefit.
- 1 September 2023
- Published by Wolters Kluwer Health in Journal of Urology
- Vol. 210 (3) , 517-528
Randomized Controlled Trial of Single-dose Perioperative Pregabalin in Ureteroscopy
Ureteroscopy is a commonly performed procedure, with post operative pain that can lead to re-visits and opioid prescribing. Perioperative gabapentinoids have shown promise in decreasing pain and opioid use. We hypothesized that single dose perioperative pregabalin would be safe and efficacious for decreasing pain after ureteroscopy. This was an IRB approved and registered blinded, placebo-controlled trial conducted at a single institution. Patients undergoing ureteroscopy without histories that would limit use of opioids, gabapentinoids, and non-steroidal medications were enrolled. Either 300mg pregabalin or placebo was administered 1 hour before ureteroscopy. Pain was assessed using a visual analogue before administration and 1 hour after surgery. Clinical factors, pain scores, a proxy for cognition, patient satisfaction, and opioid prescribing were assessed in the first 30 post operative days. 118 patients were enrolled over a 2-year period. Patients who received pregabalin were younger than those who received placebo (median of 44 years vs 57). Post operative pain scores were higher in those who received pregabalin (3.7 vs 2.0, P = .004), a finding that remained statistically significant when accounting for patient age and preoperative pain scores. There was no difference in the measure of cognition or in reports of adverse events. In this trial evaluating the efficacy of a single dose perioperative pregabalin in ureteroscopy, pregabalin did not decrease postoperative pain when compared to placebo. Urologists should not routinely use this adjunctive medication in ureteroscopy, as it is unlikely to provide benefit.
- Open Access
- 27 September 2022
- Published by Scientific Scholar in Journal of Clinical Imaging Science
- Vol. 12, 55
Coil embolization of a complex renal artery aneurysm using a new scaffold (Comaneci) device – A case report
Advances in endovascular approaches have resulted in increasing utilization of minimally invasive techniques to treat visceral artery aneurysms including renal artery aneurysms (RAAs), with high rates of success. The basic endovascular approach to treating RAAs includes stent graft exclusion or coil embolization. Treatment of RAAs with wide necks or at the bifurcation of the main vessel is facilitated by scaffolding techniques, which have been previously described. These techniques have their limitations and cannot be used in all situations. We describe a scaffolding technique using the Comaneci device (Rapid Medical, Israel), a retrievable mesh device meant for intracranial treatment of wide neck or bifurcation aneurysms that we used to safely and successfully treat a 2 cm RAA.
- 27 September 2022
- Published by Scientific Scholar in Journal of Clinical Imaging Science
- Vol. 12, 55
Open AccessCoil embolization of a complex renal artery aneurysm using a new scaffold (Comaneci) device – A case report
Advances in endovascular approaches have resulted in increasing utilization of minimally invasive techniques to treat visceral artery aneurysms including renal artery aneurysms (RAAs), with high rates of success. The basic endovascular approach to treating RAAs includes stent graft exclusion or coil embolization. Treatment of RAAs with wide necks or at the bifurcation of the main vessel is facilitated by scaffolding techniques, which have been previously described. These techniques have their limitations and cannot be used in all situations. We describe a scaffolding technique using the Comaneci device (Rapid Medical, Israel), a retrievable mesh device meant for intracranial treatment of wide neck or bifurcation aneurysms that we used to safely and successfully treat a 2 cm RAA.
- 1 December 2021
- Published by Wolters Kluwer Health in Journal of Urology
- Vol. 206 (6) , 1528-1529
SKOPE—Study of Ketorolac vs Opioid for Pain after Endoscopy: A Double-Blinded Randomized Control Trial in Patients Undergoing Ureteroscopy. Letter.
- 1 December 2021
- Published by Wolters Kluwer Health in Journal of Urology
- Vol. 206 (6) , 1528-1529
SKOPE—Study of Ketorolac vs Opioid for Pain after Endoscopy: A Double-Blinded Randomized Control Trial in Patients Undergoing Ureteroscopy. Letter.